A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer
Baruch Brenner
, Michal Sarfaty
, Ofer Purim
, Yulia Kundel
, Limor Amit
, Amir Abramovich
, Udi Sadeh Gonik
, Efraim Idelevich
, Noa Gordon
, Gal Medalia
, Aaron Sulkes
Research output: Contribution to journal › Article › peer-review
7Scopus
citations
Fingerprint
Dive into the research topics of 'A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer'. Together they form a unique fingerprint.
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science